Avricore Health, Inc. (AVCR) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a fall in Operating Profit of -690.88%, the company declared Very Negative results in Mar 25

The company has declared negative results in Jan 70 after 4 consecutive negative quarters
PRE-TAX PROFIT(Q) At CAD -0.08 MM has Fallen at -432.04%
NET PROFIT(Q) At CAD -0.08 MM has Fallen at -432.04%
NET SALES(HY) At CAD 1.86 MM has Grown at -25.16%

Risky -

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 6 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.53

Return on Equity

-40.45%

Price to Book

3.75

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Jun 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

171.74%

6 Months

233.33%

1 Year

100.64%

2 Years

-54.95%

3 Years

-55.56%

4 Years

-83.33%

5 Years

-94.59%

Avricore Health, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

32.15%

EBIT Growth (5y)

8.67%

EBIT to Interest (avg)

-0.80

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.66

Sales to Capital Employed (avg)

1.83

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.75

EV to EBIT

-5.21

EV to EBITDA

-5.21

EV to Capital Employed

5.21

EV to Sales

1.69

PEG Ratio

Dividend Yield

ROCE (Latest)

-61.93%

ROE (Latest)

-40.45%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -100.00% vs -71.43% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -400.00% vs 85.71% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.40",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.40",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.50",
          "val2": "-0.10",
          "chgp": "-400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-16,194.80%",
          "val2": "-170.00%",
          "chgp": "-1,602.48%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 37.14% vs 94.44% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 12.50% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.80",
          "val2": "3.50",
          "chgp": "37.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.60",
          "val2": "-0.30",
          "chgp": "300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.70",
          "val2": "-0.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.10%",
          "val2": "-198.50%",
          "chgp": "22.76%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

0.00

0.40

-100.00%

Operating Profit (PBDIT) excl Other Income

-0.40

-0.00

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.50

-0.10

-400.00%

Operating Profit Margin (Excl OI)

-16,194.80%

-170.00%

-1,602.48%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -100.00% vs -71.43% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -400.00% vs 85.71% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

4.80

3.50

37.14%

Operating Profit (PBDIT) excl Other Income

0.60

-0.30

300.00%

Interest

0.00

Exceptional Items

-0.80

0.00

Consolidate Net Profit

-0.70

Operating Profit Margin (Excl OI)

29.10%

-198.50%

22.76%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 37.14% vs 94.44% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 0.00% vs 12.50% in Dec 2023

All Annual Results

Company CV

About Avricore Health, Inc.

Avricore Health, Inc.

Pharmaceuticals & Biotechnology

Avricore Health Inc. is a Canada-based healthcare technology company. The Company distributes a technology platform, HealthTab, which consists of point of care screening devices and related supplies and training materials, along with a real-time data reporting networking. HealthTab is designed to offer a screening system within pharmacies to enable patients to be active about health by measuring and monitoring safety tests and biomarkers of chronic disease. Rapid Access Safety Test Reporting (RASTR), is a cloud-based network technology that enables the real-time response system to automatically report data to the consumer, healthcare team, and research entities through a Web-enabled blood chemistry analyzer, Piccolo Xpress.

Company Coordinates

Company Details

1177 West Hastings Street, Suite 2300 , VANCOUVER BC : V6E 2K3

Tel: 1 604 6872038

http://www.avricorehealth.com

Registrar Details